July 25, 2014 1:03 PM ET

Company Overview of Partnership For A Drug-Free America, Inc

Executive Profile

Mitchell S. Rosenthal M.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 1 different industries.

See Board Relationships
78--

Background

Dr. Mitchell S. Rosenthal, M.D., has been Head of Rosenthal Center for Research and Policy Studies at Phoenix House since February 2007. Dr. Rosenthal founded Phoenix House and served as its President and Chief executive Officer until February 2007. Dr. Rosenthal is a psychiatrist. Dr. Rosenthal served as a White House advisor on drug policy, a special Consultant to the Office of National Drug Control Policy and chaired the New York State Advisory Council on Alcoholism ...

Corporate Headquarters

--
--, -- --

United States

Phone: --
Fax: --

Board Members Memberships

President and Director
Director
1999-Present
Director, Chairman of Nominating Committee and Member of Compensation Committee

Education

Unknown/Other Education
Lafayette College
MD
SUNY Downstate Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Partnership For A Drug-Free America, Inc , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.